Privacy settings

Utilizziamo cookies tecnici, necessari per il corretto funzionamento del sito, cookies statistici e cookies di marketing (inclusi cookies di terze parti), al fine di mostrarti offerte e pubblicità basate sui tuoi gusti e preferenze. Per maggiori informazioni puoi consultare la nostra Privacy Policy. I cookies statistici e i cookies di marketing (inclusi cookies di terze parti) sono utilizzati esclusivamente con il tuo consenso. Cliccando “Seleziona tutto e acconsenti” consenti il trattamento dei cookies statistici e di marketing (inclusi cookies di terze parti).

Cliccando “Rifiuta tutto”, rimarranno attive le impostazioni di default del sito (ossia verranno utilizzati esclusivamente cookie tecnici necessari per la navigazione).

Per personalizzare le tue impostazioni privacy, seleziona le tue preferenze tra le caselle qui sotto e clicca “Applica la selezione”. Ti ricordiamo per puoi modificare le tue impostazioni privacy in qualsiasi momento e disattivare i cookies, seguendo le istruzioni riportate nella Privacy Policy.

Deny all Show preferences Select all and accept
IMA is loading

ISPE Summer Night on Emerging Technologies and Continuous Manufacturing • Milano (Italy), 11 July 2019

Post published on 01/07/2019

IMA Active is pleased to be sole sponsor of the ISPE Summer Night on Emerging Technologies and Continuous Manufacturing

IMA Active is pleased to take part in the ISPE Summer Night on Emerging Technologies and Continuous Manufacturing, which will be held in Milan (Italy), on July 11, 2019.

ISPE Italy, in collaboration with AFI, thanks to the involvement of leading experts on oral solid pharmaceutical forms presents some emerging technologies for Drug Delivery and Continuous Manufacturing. Innovate and modernize the manufacturing process for pharmaceuticals to ensure maximum quality of medicines and make them available is now a global priority.
Today innovation rest on digitalization of business processes and Pharma 4.0 and Regulatory Authorities themselves are active on this front. FDA is promoter of this change through the OPC (Office of Pharmaceutical Quality) focusing on the drug’s life cycle: chemistry, manufacturing and controls (CMC). Undoubtedly, the most important regulatory initiative lies in the Emerging FDA Technology Program (ETP), which serves the purpose to encourage the development and adoption of emerging technologies in order to obtain a manufacturing system of medicines even more efficient, agile and flexible.
Continuous Manufacturing is recognized as the more imminent and promising change: ISPE has recently created an international Community of Practice, bringing together the main stakeholders to share and exchange knowledge and drive the development of this new paradigm.
Sole sponsored by IMA Active, theme of the conference is emerging technologies in pharmaceuticals, with a special insight on Continuous Manufacturing for Oral Solid Dosage forms. 2019 ISPE Summer Night is a must-attend event for pharmaceutical professionals that will bring together industry, regulatory and academic leaders to share their expert insights through case studies and interactive discussions.
Guia Bertuzzi, IMA Active Product Manager and ISPE Italy former Vice President, will introduce the event giving the presentation “ISPE CoP for Continuous Manufacturing”.

Discover more »

In collaboration with

Get in touch

For any further information,

Other Updates

keyboard_arrow_left keyboard_arrow_right